4.7 Article

Health impacts of increasing alcohol prices in the European Union: A dynamic projection

Journal

PREVENTIVE MEDICINE
Volume 55, Issue 3, Pages 237-243

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ypmed.2012.06.006

Keywords

Alcohol drinking; European Union; Taxes

Funding

  1. EU of the European Commission's Directorate General for Health and Consumer Affairs (DG SANCO)
  2. Erasmus Medical Center Rotterdam
  3. Institute of Public Health and the Environment in the Netherlands
  4. Catalan Institute of Oncology
  5. International Obesity task force
  6. London School for Hygiene and Tropical Medicine
  7. Haughton Institute in Dublin
  8. Fondazione IRCCS Istituto Nazionale Tumori in Milan

Ask authors/readers for more resources

Objective. Western Europe has high levels of alcohol consumption, with corresponding adverse health effects. Currently, a major revision of the EU excise tax regime is under discussion. We quantify the health impact of alcohol price increases across the EU. Data and method. We use alcohol consumption data for 11 member states, covering 80% of the EU-27 population. and corresponding country-specific disease data (incidence, prevalence, and case-fatality rate of alcohol related diseases) taken from the 2010 published Dynamic Modelling for Health Impact Assessment (DYNAMO-HIA) database to dynamically project the changes. in population health that might arise from changes in alcohol price. Results. Increasing alcohol prices towards those of Finland (the highest in the EU) would postpone approximately 54,000 male and approximately 26,100 female deaths over 10 years. Moreover, the prevalence of a number of chronic diseases would be reduced: in men by approximately 97,800 individuals with diabetes, 65,800 with stroke and 62,200 with selected cancers, and in women by about 19,100, 23,500, and 27,100, respectively. Conclusion. Curbing excessive drinking throughout the EU completely would lead to substantial gains in population health. Harmonisiation of prices to the Finnish level would, for selected diseases, achieve more than 40% of those gains. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available